Patent · US Active

Pharmaceutical formulation containing irritant

US8652497B2 · kind B2 · utility

90Cited by
32References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 20, 2010
Grant dateFeb 18, 2014
Priority date
Expiry dateAug 21, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/5026
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.